1,4,7,10,13,16-HEXAOXACYCLOOCTADECANE
General Information
Mainterm | 1,4,7,10,13,16-HEXAOXACYCLOOCTADECANE |
CAS Reg.No.(or other ID) | 17455-13-9 |
Regnum |
177.2400 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 28557 |
IUPAC Name | 1,4,7,10,13,16-hexaoxacyclooctadecane |
InChI | InChI=1S/C12H24O6/c1-2-14-5-6-16-9-10-18-12-11-17-8-7-15-4-3-13-1/h1-12H2 |
InChI Key | XEZNGIUYQVAUSS-UHFFFAOYSA-N |
Canonical SMILES | C1COCCOCCOCCOCCOCCO1 |
Molecular Formula | C12H24O6 |
Wikipedia | 18-crown-6 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 264.318 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 0 |
Complexity | 108.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w O A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A A A A A A A C g g A I A A A A A B A A A A A A A A A A A A A A A A A A A A A A A A A A B A A A A A A A C A A A A A A A C A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 55.4 |
Monoisotopic Mass | 264.157 |
Exact Mass | 264.157 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 18 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9583 |
Human Intestinal Absorption | HIA+ | 0.9662 |
Caco-2 Permeability | Caco2+ | 0.5466 |
P-glycoprotein Substrate | Non-substrate | 0.6822 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9357 |
Non-inhibitor | 0.9823 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8345 |
Distribution | ||
Subcellular localization | Mitochondria | 0.6027 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8956 |
CYP450 2D6 Substrate | Non-substrate | 0.8496 |
CYP450 3A4 Substrate | Non-substrate | 0.7385 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9047 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8994 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9597 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8978 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9812 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9589 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8574 |
Non-inhibitor | 0.9475 | |
AMES Toxicity | Non AMES toxic | 0.9132 |
Carcinogens | Non-carcinogens | 0.8461 |
Fish Toxicity | Low FHMT | 0.9550 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.6196 |
Honey Bee Toxicity | High HBT | 0.6367 |
Biodegradation | Not ready biodegradable | 0.5070 |
Acute Oral Toxicity | III | 0.8135 |
Carcinogenicity (Three-class) | Non-required | 0.4475 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -0.6245 | LogS |
Caco-2 Permeability | 1.0998 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.2253 | LD50, mol/kg |
Fish Toxicity | 3.6048 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -0.8734 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic oxygen compounds |
Class | Organooxygen compounds |
Subclass | Ethers |
Intermediate Tree Nodes | Not available |
Direct Parent | Dialkyl ethers |
Alternative Parents | |
Molecular Framework | Aliphatic heteromonocyclic compounds |
Substituents | Oxacycle - Organoheterocyclic compound - Dialkyl ether - Hydrocarbon derivative - Aliphatic heteromonocyclic compound |
Description | This compound belongs to the class of organic compounds known as dialkyl ethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are alkyl groups. |
From ClassyFire